$15M NIDA Grant Awarded to Serena Spudich, Mark Gerstein, and Yuval Kluger
Principal Investigators Serena Spudich, MD, MA (Neurology), Mark Gerstein, PhD (Molecular Biophysics and Biochemistry), and Yuval Kluger, PhD (Pathology) were recently awarded a $15 million grant from the National Institute on Drug Abuse (NIDA) to establish a Data Center to coordinate, analyze, and make accessible single-cell and other molecular data sets generated by Single-Cell Opioid Responses in the Context of HIV (SCORCH) and other NIDA-funded HIV and substance use disorder projects.
Yale Scientists Awarded $8.4M Grant to Develop Treatments for Women With Problem Drinking
Yale Department of Psychiatry scientists have been awarded a five-year, $8.4 million federal grant to establish a new research center at Yale that will develop treatments to help women with problem drinking.
Teen vaping is bad. Nicotine makes it worse, says researcher
Companies that make vaping liquids must now comply with a U.S. Food and Drug Administration policy released last month banning vape liquids that taste like anything but tobacco or menthol. But vaping still delivers something highly appealing and addictive: nicotine. And researchers are just beginning to study the drug’s long-term impact on the developing brain.Source: Science Mag
As the Vaping Epidemic Continues, Researchers Point to Well-known Health Risks Associated with Nicotine
Despite the onslaught of reports and articles highlighting not only the dangers of vaping, but the marketing tactics seemingly aimed to hook teens and young adults, the number of people who vape continues to climb.Source: Yale Medicine
Will Low-Nicotine Cigarettes Stop People From Smoking? Yale Prof Says Answer Is Not Clear
Will low-nicotine cigarettes help with addiction? The answer is unclear, according to Dr. Marina Picciotto, Professor of Psychiatry and Professor of Neurobiology and Pharmacology, Yale University School of Medicine.Source: WNPR
Picciotto to become President of Society for Research on Nicotine & Tobacco
Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, and Deputy Chair for Basic Science Research in the Yale Department of Psychiatry, will become President of the Society for Research on Nicotine & Tobacco (SRNT) in the Spring.
Yale study: Effects of maternal smoking continue long after birth
Early exposure to nicotine can trigger widespread genetic changes that affect formation of connections between brain cells long after birth, a new Yale-led study has found. The finding helps explains why maternal smoking has been linked to behavioral changes such as attention deficit and hyperactivity disorder, addiction and conduct disorder.
Picciotto named editor-in-chief of The Journal of Neuroscience
Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and Professor in the Child Study Center, of Neuroscience and of Pharmacology, and Deputy Chair for Basic Science Research in the Department of Psychiatry, has been named editor-in-chief of The Journal of Neuroscience.
Hypertension medication that targets stress may help smokers quit
Smokers trying to quit often light up a cigarette to deal with stress. Now an interdisciplinary team of Yale researchers has shown that guanfacine, a medication approved for treating hypertension that reduces stress and enhances cognition, shows promise as a smoking cessation aid.
Addiction: Can the Brain Control Our Uncontrollable Urges?
A U.N. commission recently announced a unanimous scientific consensus that addiction is a disease of the brain. Three neuroscientists discuss this consensus, as well as the biology of addiction and prospects for improved pharmacological treatments.
Five questions with Marina Picciotto, PhD
Marina Picciotto, PhD, Charles B.G. Murphy Professor of Psychiatry and professor in the Child Study Center, of neurobiology, and of pharmacology, discusses her research interests, describes what makes Yale such a great community for investigators, explains the department's expanded Translational Neuroscience Initiative, and shares some advice for junior faculty.
Stressed Out and Locked-Down During Pandemic, New Yorkers Craved Alcohol, YSPH Study Finds
As New York state’s lockdown orders wore on in the early months of the COVID-19 pandemic, residents increasingly felt cravings for alcohol — and reported subsequently misusing it, a new study from scientists at the Yale School of Public Health and Stony Brook University has found.
Here’s how Connecticut can move beyond the harm of the War on Drugs
In the 1990s, then-Senator Joe Biden and others pushed a War on Drugs, a war that had a tremendous negative impact on our state. Prison populations soared; over a third of young men of color were under criminal justice supervision; and drug use and attendant public health consequences proceeded unabated.Source: CT Mirror
Pandemic-based Approach to Methadone Treatment Restrictions Should Remain, YSPH Study Finds
When the COVID-19 pandemic ripped through New England and the rest of the United States in early 2020, substance use disorder treatment centers were forced to make massive changes to minimize the spread of coronavirus.
The Overdose Crisis: Harm Reduction in U.S. Health Policy
On May 20, Yale’s Department of Internal Medicine and Program in Addiction Medicine hosted its first event on Clubhouse, a social networking app that allows members to gather in audio chat rooms and discuss issues in a live podcast style. The event focused on the drug overdose in the United States and incorporation of harm reduction into U.S. health policy and practice.
WHRY Funds Studies on Heart Disease, Insomnia, and Pain
Women’s Health Research at Yale today announced funding for three new studies investigating a method for improving the diagnosis of heart disease in women, a therapy for clinically significant sleep disruption common in Black women, and the influence of biological sex on the underlying brain patterns that link pain and opioid use.